Oury Medical, an independent French industrial group specialized in the manufacturing of medical instrumentation, announces the acquisition of Céfiméca, a leading player in the manufacturing of orthopedic and spinal instruments and implants.
This transaction represents a new major step in the development of the Oury Medical group and is fully in line with the long-term industrial strategy initiated by TAG Partners at the time of the acquisition of Oury-Guyé three years ago.
Since this founding acquisition, TAG Partners has actively supported the transformation of the group with a clear ambition: to build a leading player in orthopedic and spinal medical instrumentation by aggregating complementary high value-added manufacturing know-how. This strategy has been executed through a series of targeted acquisitions. The acquisition of Céfiméca constitutes the fifth build-up operation carried out since the launch of this platform strategy.
Céfiméca brings recognized expertise in orthopedic and spinal instruments, complemented by a focused and high-value range of implants for which its precision manufacturing capabilities are particularly recognized. This combination strengthens Oury Medical’s positioning as a partner offering a fully integrated One-Stop-Shop offering for its clients in orthopedic medical instrumentation.
This acquisition is financed by TAG Partners and ISALT, an independent French asset management company, alongside several family offices and private investors. This new financing round aims both to finance the acquisition of Céfiméca and to strengthen the group’s balance sheet, enabling the continuation of investments in technology, industrial capacities and growth.
With 5 production sites in France and a workforce of over 200 employee, Oury Medical further strengthens its ability to serve major players in orthopedics and spinal surgery, with a comprehensive One-Stop-Shop offering, coordinated with consistent quality, technical depth and long-term reliability.
“When we acquired Oury-Guyé three years ago, our ambition was clear: to build a leading French industrial platform in orthopedic and spinal medical instrumentation through a disciplined build-up strategy. Since then, we have completed five acquisitions to progressively assemble complementary know-how. The acquisition of Céfiméca fully fits within this vision and further strengthens Oury Medical’s positioning as a strategic partner for our orthopedic clients with a One-Stop-Shop offering.”
“This acquisition marks an important step in the execution of our strategy. By integrating complementary capabilities in instrumentation and focused and high-value range of implants, we further strengthen the value we bring to our clients, while remaining focused on our industrial DNA.”
“For more than 25 years, Céfiméca has developed strong expertise in orthopedic and spinal instruments and implants. Joining Oury Medical allows us to leverage complementary capabilities and to continue our development within a broader and more ambitious industrial platform.”
Sébastien Meunier, CEO | Oury Medical Group [email protected] | +33 6 24 64 08 23
Gianfranco Viola, Chief Commercial Officer | Oury Medical Group [email protected] | +33 6 68 15 86 78
Oury Medical is an independent French group, specialized in the manufacturing of surgical instruments for orthopedics and spine. With more than 100 years of expertise, the Group supports its clients from design to production of standard and custom instruments.
Oury Medical relies on three production sites in France, in Nogent, Chaumont and Grenoble, and offers a “One-Stop Solution” approach covering design, manufacturing, kitting and re-kitting of complete trays, as well as maintenance and management of instruments throughout their lifecycle. The Group is led by an experienced management team, serving clients worldwide.
Céfiméca is specialized in the manufacturing of high-precision surgical instruments and orthopedic implants. The company supports its clients from prototype to serial production for numerous joint applications.
Céfiméca operates two production sites in Saint Étienne and its surrounding area and stands out for its high level of requirements in terms of quality, regulatory compliance and customer service. It relies on recognized know-how in precision mechanics and a continuous improvement approach.
TAG Partners is an independent investment firm operating under an Independent Sponsor model co-founded and led by Georges-Alexandre Ancenys, Thierry Manceau and André Wagner. Its mission: to support high-potential French SMEs in ownership transition, transformation and growth.
The founding partners combine CEO and investor experience to lead value creation and transition projects around three priority areas:
TAG Partners operates under an Independent Sponsor model and brings together for each investment a pool of co-investors (entrepreneurs, family offices, sector experts) in order to create a dynamic of exchange and co-construction with the management teams of the supported companies.
Discussion
Join the discussion
Sign in and subscribe to post comments.
No comments yet. Be the first to share your thoughts.